Skip to main content

Table 2 Characteristics of the HBV-related decompensated cirrhosis patients

From: Plasma diamine oxidase level predicts 6-month readmission for patients with hepatitis B virus-related decompensated cirrhosis

  Readmission (n = 36) Non-Readmission (n = 135) P Value
Male* (%) 28(77.8%) 68(68.7%) 0.303
Age (year) 59(53–61.6) 58(53–61) 0.574
HBeAg(+)*, n(%) 27(75%) 63(63.6%) 0.215
HBsAg 4122.5(3276.3–6266.0) 4477.0(3634.0–6326.0) 0.282
HBV-DNA(+)*, n(%) 27(75%) 72(72.7%) 0.792
ALT (IU/L) 72.0(54.3–109.5) 85.0(65.0–132.0) 0.105
AST (IU/L) 91.0(55.0–145.5) 79.0(45.0–114.0) 0.307
TBIL (μmol/L) 41.4(26.1–67.9) 39.8(27.0–56.9) 0.508
ALB (g/L) 30.9(26.7–34.6) 34.6(32.0–37.9) 0.042
PTA (%) 70.0(61.3–85.8) 75.0(63.0–88.0) 0.233
Cr (μmol/L) 89.0(68.5–93.8) 73.0(66.0–87.0) 0.087
WBC (109/L) 4.5(2.9–9.0) 4.7(3.0–11.4) 0.807
HGB (g/L) 115.5(89.5–129.8) 125.0(111.0–137.0) 0.019
PLT (109/L) 73.5(66.0–123.3) 90.0(54.0–133.0) 0.464
SBP*, (n,%) 10(27.8%) 11(11.1%) 0.018
Ascites*, (n,%) 31(86.1%) 81(81.8%) 0.557
GI bleeding*, (n,%) 15(41.7%) 12(12.1%) 0.000
HE*, (n,%) 10(27.8%) 8(8.1%) 0.003
Child-pugh A/B/C*, n(%) 0/16/20(0%/44.4%/55.6%) 0/74/25(0/74.7%/25.3%) 0.001
  1. Quantitative variables were expressed as the median (centile 25; centile 75)
  2. * Categorical variables were expressed as n (%)